BYStreptomyces hygroscopicus
Yoichi KuMADAf,Satoshi Imai and Kozo Nagaoka Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd., Morookacho, Kohoku-ku, Yokohama222, Japan (Received for publication March 6, 1991) Twooligopeptides containing phosphinothricin were accumulated in the culture of bialaphos (BA) producer Streptomyces hygroscopicus SF1293 when large amount of BAwas added to the culture at idio phase. One of the oligopeptides was a new substance, BA dimer (phosphinothricyl-alanyl-alanyl-phosphinothricyl-alanyl-alanine), and the other was a known substance called
If (phosphinothricyl-alanyl-alanyl-phosphinothricin). Though BAnone producing mutants which were blocked at the steps 1, 10 and 13, respectively in BAbiosynthesis also converted BA to BA dimer and If, the mutants blocked at the step 1 1 (alanylation) could not curry out the conversion. Antibiotic activities of BAdimer and If were lower than 1/100 of BA. The biosynthetic pathway of BAwas proposed by Seto et al.6~9\ and Imai et al.10~12) on the basis of the identification of the intermediates accumulated by various blocked mutants and their conversion by the mutants (see Fig. 2 ). Though BAis the main product of SF1293, it is produced as one ofa number of products which have PPT in common in their structure, i.e., several analogous substances, la (PPT-Gly-Ala), Ib (PPT-Ala-Gly), Ic (PPT-Ala-a-amino butylic acid (ABA)), Id (PPT-Ala-Val), le (PPT-Ala-Ser), If (PPT-Ala-Ala-PPT), were known as minor components so far13).
Weshow in this paper the pathway for the biosynthesis of one such minor components, If, and a novel substance, BA dimer, and discuss the physiological significance of their production.
Materials and Methods
Strains and Media BA producer S. hygroscopicus SF1293 strain HP5-29 and BAnone producing mutants NP47, NP2007-1, NP2008-1, Bar"/pGSCl, NP61, NP62, MNP17, MNP18, NP8 were obtained from the Meiji Seika collection6^12 '14) . Media (S1? BA production and minimum medium) and culture conditions are described by Ogawa Cultivation for Conversion of BA The stock culture of BAproducer S. hygroscopicus SF1293 or its mutants was subcultured in 10ml of Sx medium at 28°C for 24 hours. One ml of the seed was transferred to 30ml of production medium in 250ml conical flask and cultured by rotary shaker (220rpm) at 30°C. BA was added at 3rd~5th day.
Assay of Products
The culture broth was diluted with water, heated for 5 minutes in boiling water to extract the intracellular substances and centrifuged. The resulting supernatant was used for the assay. BAdimer, If and BA were analyzed by HPLCas described in the previous paper14). An amino acid analyzer (ATTO MLC-703)was also used for the assay of the above three substances and PPT.
Purification of BADimer and If
Sample for Purification: The nonproducing mutant NP47 was cultivated for 3 days and BA was added to the culture (final cone 35 mg/ml). The culture added BAwas further cultivated for 3 days and was used for the purification. The whole broth (240ml) was adjusted to pH 2.0 and agitated for 30 minutes to extract the compoundin the cell. After centrifugation to separate mycelia, the supernatant was used for the isolation of BAdimer and If.
Purification (See Table 1 ): Purification of BAdimer and If is summarized in Table 1 .
Structural Analysis NMR:NMRspectrophotometer JNM-GX400was used. SI-MS Spectrum: Mass spectrophotometer M-80B (Hitachi) was used. Amino Acid Composition: A sample (73 fig) was dissolved in 50fA of distilled water and 50//I of 12n HC1was added to the solution and the mixture was poured into an ampoul (8 x 100mm)and sealed after degassing under low pressure. Hydrolysis was carried out at 1 10°C for 17 hours, after which the sample was evaporated completely and 500/il of 20mMHC1was added. Aminoacid composition was analyzed by an automatic amino acid analyzer L-8500 (Hitachi).
Amino Acid Sequence Analysis: A sample (7.3 fig) was dissolved in 5 fi\ of distilled water and used for aminoacid sequence analysis. The analysis was carried out by using a protein sequencing system 450A (Applied Bio System).
Measurement of Antiboitic Activity Antibiotic activity was assayed using Bacillus subtilis 8193 and S. hygroscopicus SF1293 Bar" 14). The strain S. hygroscopicus SF1293 Bar" were streaked on the minimal medium2) supplemented with BA, BA dimer and If, respectively, and were incubated at 28°C for 3 days. In the case of B. subtilis 8193 as the indicator, paper discs containing 1 fig of BAdimer, If and BA, respectively, were plated on the nutrient BAwas added to 3 days cultures and the cultures were further cultivated for 2 days. Step 1
Step 1
Step 10
Step ll
Step 13 * Bar mutant is very sensitive to BAbecause its blocked point step 10 (acetylation) is also involved in self-defence. Therefore, pGSCl that is a high copy number plasmid containing a GS gene from Streptomyces coelicolor18) was introduced into the Bar" mutant to confer BAresistance to the mutant13). The converting ability of the mutants is expressed by the ratio of BA converted as +:^5%, +: <5% and -: notdetected.
agar mediumsupplemented with the strain and the plate was incubated at 37°C for 1 day. Antibiotic activity was estimated from the diameter of the growth inhibitory zones. THE JOURNAL OF ANTIBIOTICS 1009 SF1293 strain HP5-29. As the result, a considerable amount of BAdimer and If were accumulated. As shown in Fig. 3 , notable accumulation of both substances was recognised when over 20mgof BAwas added to the culture. The same results were obtained in the case of various blocked mutants, NP47(step 1 blocked), Bar~/pGSCl* (step 10 blocked) and NP8 (step 13 blocked) ( Table 2 ). On the other hand, mutants (NP61, NP62, MNP17and MNP18) that were blocked at the alanylation step of BA could not accumulate either substance ( Table 2) .
Results

Conversion of BAto BADimer and If
Structure of BA Dimer BAdimer was obtained as a colorless powder which was soluble in water and positive to ninhydrin. The molecular formula of BA dimer was determined to be C22H42N6OHP2from SI-MS data (m/z 629 (M+H)+, 651 (M+Na)+) and AH and 13C NMRdata (Tables 3 and 4) . On acid hydrolysis, BA dimer gave alanine and PPT which was detected by amino acid analyzer and their molar ratio was 2 : 1. Considering the molecular formula, it is concluded that BAdimer consists of 4mol of alanine and 2mol of PPT. The structure of BAdimer was determined to be phosphinothricyl-alanyl-alanyl-phosphinothricyl-alanyl-alanine by amino acid sequence analysis. (Tables  3 and 4 ). Acid hydrolysis of If followed by amino acid analysis revealed that If consisted of 2mol of alanine and 2mol of PPT. The structure of If was determined to be phosphinothricyl-alanyl-alanyl- Antibiotic Activities of BADimer and If Antibiotic activities of BAdimer and If using B. subtilis and Bar" mutant defecting detoxication nodification (TV-acetylation) as the indicators were lower than one hundredth of that of BA, e.g. 100 jUg/ml )fBA dimer or If did not inhibit the growth of the Bar~mutant, on the other hand, 1^g/ml ofBA inhibited it.
Discussion
The results of the accumulation of BAdimer and If when a large amount of BAwas added to the various blocked mutants show that these substances were not generated by de novo synthesis but by the conversion of BA. The result also showed that the blocked mutants defective in step 1 1 (alanylation) could lot convert BAto these substances, indicating that the enzyme catalysing the alanylation step in BAde tovo biosynthesis is also involved in this conversion. The proposed BAbiosynthetic pathway is shown in Fig. 2 . As shown in this figure, the substrate of ilanylation step is the iV-acetylated intermediate (JV-acetyl demethylphosphinothricin (DMPT) or PPT). 3n the contrary, the acetylation step (step 10) is not necessary in the case of BAdimer or If formation because the Bar" mutant defective in the 7V-acetylation step14) also can convert BAto BAdimer and If. Dresumably, though the enzyme involved in the alanylation of DMPTor PPTrequires strictly that the imino group of the substrate be acetylated, the same enzyme can convert BAinto BAdimer or If without he acetylation of BA. The presumptive process of BAdimer and If formation is illustrated in Fig. 4 . PPT is a structural component of BAand is a strong GSinhibitor4'5). PPT also inhibits SF1293 GrS (S. Imai; personal communication). Though the primary self defence mechanism of SF1293 in the production of BAis knownto be the acetylation of PPT5), quantitative change of GSis also involved, ;ince an increase of GS activity accompanied by BA accumulation is observed during BA production16). Qualitative change of the GS is also supposed to be involved, since SF1293 has two GSs and one of them jrSII-Sh is more resistant to PPT than the other GS, GSI-Sh17), but the crucial proof is not obtained because the expression of GS II-Sh in SF1293 was not well recognised so far.
Finally, we will discuss the physiological significance of the conversion in relation to the self defence. suggest that the high concentration of BA affects to the physiological activity of the BAproducer and the conversion of BAto these oligopeptides maydiminish the toxic effect of BAand mayplay a role of a self defense in the presence of high concentration of BA.
